OPK OPKO Health Inc.

OPKO Health to Participate in the Jefferies Global Healthcare Conference

OPKO Health to Participate in the Jefferies Global Healthcare Conference

MIAMI, May 31, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Jefferies Global Healthcare Conference, being held June 4-6, 2024 at the Marriott Marquis in New York City. Management will be holding one-on-one meetings with investors and will be participating in a fireside discussion on Thursday, June 6th at 10:30 a.m. Eastern time.

The fireside chat will be webcast live and available for replay in the Investors section of OPKO Health’s website and accessible by clicking .

About OPKO Health

OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit .

Contacts:

LHA Investor Relations

Yvonne Briggs, 310-691-7100



or

Bruce Voss, 310-691-7100



EN
31/05/2024

Underlying

OPKOPKO Health Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on OPKO Health Inc.

 PRESS RELEASE
Free
OPK OPKO Health In...

OPKO Health Reports Second Quarter 2024 Business Highlights and Financ...

OPKO Health Reports Second Quarter 2024 Business Highlights and Financial Results Conference call begins at 4:30 p.m. Eastern time today MIAMI, Aug. 07, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three and six months ended June 30, 2024. Highlights from the second quarter and recent weeks include the following: Enrollment underway in the MDX2001 Phase 1 trial for the treatment of solid tumor cancers. MDX2001, a tetraspecific antibody, is designed to optimize T-cell function to stimulate tumor regression while mini...

August 7, 2024 1 EN
 PRESS RELEASE
Free
OPK OPKO Health In...

OPKO Health to Report Second Quarter 2024 Financial Results on August ...

OPKO Health to Report Second Quarter 2024 Financial Results on August 7, 2024 MIAMI, Aug. 01, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and six months ended June 30, 2024 after the close of the U.S. financial markets on Wednesday, August 7, 2024. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on August 7th beginning at 4:30 p.m. Eastern time. CONFERENCE CALL & WEBCAST INFORMATION OPKO encourages participan...

August 1, 2024 1 EN
 PRESS RELEASE
Free
OPK OPKO Health In...

OPKO Health Announces $100 Million Share Repurchase Program

OPKO Health Announces $100 Million Share Repurchase Program MIAMI, July 18, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that its Board of Directors has authorized the repurchase of up to $100 million of shares of the Company's common stock.   Under the repurchase program, OPKO may repurchase shares of its common stock from time to time through open market purchases, block trades, privately negotiated transactions, accelerated share repurchase transactions and/or pursuant to Rule 10b5-1 plans, in compliance with applicable securities laws and other legal requir...

July 18, 2024 1 EN
 PRESS RELEASE
Free
OPK OPKO Health In...

OPKO Health and HealthCare Royalty Enter into $250 Million Note Purcha...

OPKO Health and HealthCare Royalty Enter into $250 Million Note Purchase Agreement Secured by NGENLA’s Profit Share Payments MIAMI, July 17, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) announces it has entered into a $250 million non-dilutive note purchase agreement with HealthCare Royalty (HCRx) secured by OPKO’s profit share payments from Pfizer received pursuant to its license agreement relating to NGENLA™, a once-weekly treatment currently marketed to treat pediatric growth hormone deficiency. “This transaction with HCRx allows OPKO to retain a significant portion of NGE...

July 17, 2024 1 EN
 PRESS RELEASE
Free
OPK OPKO Health In...

OPKO Health to Participate in the Jefferies Global Healthcare Conferen...

OPKO Health to Participate in the Jefferies Global Healthcare Conference MIAMI, May 31, 2024 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (Nasdaq: OPK) announced today that management will be participating in the Jefferies Global Healthcare Conference, being held June 4-6, 2024 at the Marriott Marquis in New York City. Management will be holding one-on-one meetings with investors and will be participating in a fireside discussion on Thursday, June 6th at 10:30 a.m. Eastern time. The fireside chat will be webcast live and available for replay in the Investors section of OPKO Health’s website and...

May 31, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch